Skip to main content
OpenTrials
Completed

NCT Number: NCT03964168

An Outcomes Study to Determine the Reasons Patients on Biologic Therapy Discontinue Treatment and Fail to Follow-up With Their Providers

Patient interviews to evaluate the reason patients discontinue biologic therapy and/or fail to follow up with provider.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Psoriasis Skin Diseases Skin Diseases, Papulosquamous Skin and Connective Tissue Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Psoriasis Treatment Center of Central New Jersey

East Windsor, New Jersey, 08520, United States

About this study

Retrospective chart review and patient interviews to evaluate the reason patients discontinue biologic therapy and/or fail to follow up with provider. This research intends to improve the continuity of care by determining why patients stop therapy and what can be done to improve their experience with the provider, pharmaceutical companies and specialty pharmacies.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male or female adults ≥ 18 years of age.
  • Was receiving first or second biologic therapy
  • Has not had a follow up with treating physician in ≥ 9 months

Exclusion criteria

  • Actively receiving biologic therapy
  • Was not receiving first or second biologic therapy

Treatment and study plan

Biologic Agent

Drug

Patients who discontinued a bioloic agent

Primary outcomes

  1. Determine the most common reason for discontinuation

    Time frame: 5 years

    Tally number of patients who discontinued due to adverse events, insurance issues or category other.

Sponsors and collaborators

Lead sponsor

Psoriasis Treatment Center of Central New Jersey

Other

Collaborators

  • Janssen Scientific Affairs, LLC

Registry information

Important dates

Study start
2019
Primary completion
2020
Study completion
2020
First posted
May 28, 2019
Registry last updated
Mar 11, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.